Ann: AGM 2018 Presentation, page-23

Its 100% concentrating on getting cashflow positive. All working capital is geared towards this objective and we are well on target to achieve that by the stated June quarter next year.

The lung device is ready for commercialisation but I think they would prefer a partner to run with it.

I mentioned the idea of spinning out the project(s) and that is also a possibility down the track.

Sensera appears to be an incubator for many worthwhile blue sky projects but the name of the game is to go deep into our existing markets where our tech is being rolled out.